Abstract
Get full access to this article
View all access options for this article.
References
1.
Petratos
S
Ozturk
E
Azari
MF
. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation . Brain 2012 ; 135 : 1794 –1818 .
2.
Trapp
BD
Peterson
J
Ransohoff
RM
. Axonal transection in the lesions of multiple sclerosis . N Engl J Med 1998 ; 338 : 278 –285 .
3.
Frischer
JM
Bramow
S
Dal-Bianco
A
. The relation between inflammation and neurodegeneration in multiple sclerosis brains . Brain 2009 ; 132 : 1175 –1189 .
4.
Tsakiri
A
Kallenbach
K
Fuglø
D
. Simvastatin improves final visual outcome in acute optic neuritis: A randomized study . Mult Scler J 2012 ; 18 : 72 –81 .
5.
Arun
T
Tomassini
V
Sbardella
E
. Targeting ASIC1 in primary progressive multiple sclerosis: Evidence of neuroprotection with amiloride . Brain 2013 ; 136 : 106 –115 .
6.
Chang
A
Staugaitis
SM
Dutta
R
. Cortical remyelination: A new target for repair therapies in multiple sclerosis . Ann Neurol 2012 ; 72 : 918 –926 .
7.
Mi
S
Miller
RH
Lee
X
. LINGO-1 negatively regulates myelination by oligodendrocytes . Nat Neurosci 2005 ; 8 : 745 –751 .
8.
GrandPré
T
Nakamura
F
Vartanian
T
. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein . Nature 2000 ; 403 : 439 –444 .
9.
Kwon
BK
Sekhon
LH
Fehlings
MG
. Emerging repair, regeneration, and translational research advances for spinal cord injury . Spine 2010 ; 35 (21 Suppl ): S263 –270 .